Also trades as: RX.V (TSXV) · $vol 0M
BIOYF OTC
BioSyent Inc.
1W: -2.8%
1M: +0.2%
3M: +11.4%
YTD: +23.4%
1Y: +35.0%
3Y: +100.9%
5Y: +112.0%
$11.49
-0.01 (-0.09%)
Weekly Expected Move ±6.0%
$10
$11
$11
$12
$13
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$10M
+10.9% ▲
5Y CAGR: +6.9%
Capital Expenditures
$54K
+98.8% ▲
5Y CAGR: -20.9%
Free Cash Flow
$10M
+139.3% ▲
5Y CAGR: +7.3%
Dividends Paid
$2M
-8.2% ▼
Buybacks
$1M
+80.5% ▲
Net Change in Cash
$11M
+168.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $6M | $5M | $6M | $7M | $9M |
| Depreciation & Amort. | $457K | $451K | $455K | $590K | $852K |
| Stock-Based Comp. | $334K | $440K | $513K | $554K | $0 |
| Change in Working Capital | -$2M | -$1M | -$1M | $888K | -$906K |
| Other Non-Cash Items | -$155K | -$299K | -$789K | -$509K | $749K |
| Operating Cash Flow | $5M | $5M | $5M | $9M | $10M |
| — Investing Activities — | |||||
| Capital Expenditures | -$93K | -$519K | -$59K | -$42K | -$389K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$5M | -$11M | -$2M | -$8M | -$3M |
| Investment Sales | $0 | $0 | $3M | $14M | $7M |
| Other Investing | $146K | $384K | $814K | -$3M | $92K |
| Investing Cash Flow | -$5M | -$11M | $884K | $3M | $3M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$152K | -$162K | -$174K | -$183K | $0 |
| Stock Repurchased | -$2M | -$4M | -$3M | -$5M | -$1M |
| Dividends Paid | $0 | -$484K | -$2M | -$2M | -$2M |
| Other Financing | -$75K | -$37K | -$2K | -$389K | -$246K |
| Financing Cash Flow | -$2M | -$4M | -$6M | -$8M | -$3M |
| Net Change in Cash | -$2M | -$10M | $120K | $4M | $11M |
| Cash End of Period | $18M | $8M | $8M | $12M | $20M |
| Free Cash Flow | $5M | $4M | $5M | $4M | $10M |